Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lorenzo Carriera
Observed names:
L., Carriera,
Lorenzo CARRIERA,
Lorenzo Carriera1,2
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Azienda Ospedaliera di Perugia,
Ospedale Santa Maria,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Azienda Ospedaliera di Perugia,
Ospedale Santa Maria,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0006-2538-1278
Observed ORCID:
0009-0006-2538-1278
OpenAlex ID:
A5093239236
Combination of Biological Therapy in Severe Asthma: Where We Are?
2023
·
Lorenzo Carriera
, Marta Fantò
, et al.
·
Journal of Personalized Medicine
·
45
PDF
Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel Pathways
2026
·
Lorenzo Carriera
, Roberto Lipsi
, et al.
·
Biomedicines
·
20
PDF
Mucus Plugging as a Treatable Trait Across the Asthma–COPD Spectrum: The Role of Type 2 Cytokine Blockade and Quantitative Imaging
2026
·
Pier-Valerio Mari
, Alberto Ricci
, et al.
·
Biomedicines
·
9
Potential novel role of asthma biologics as rescue therapy in the intensive care unit for life-threatening asthma exacerbations: a systematic review
2025
·
Lorenzo Carriera
, Pier Valerio Mari
, et al.
·
Monaldi Archives for Chest Disease
·
9
PDF
The Impact of Corticosteroids on Mortality in Acute Exacerbations of Idiopathic Pulmonary Fibrosis: A Meta-Analysis
2025
·
Pier-Valerio Mari
, Angelo Coppola
, et al.
·
Advances in respiratory medicine
·
9
Impact of IL-4/IL-13 Blockade with Dupilumab on the Microbiome in Type 2 Inflammatory Diseases: A Systematic Review
2026
·
Pier-Valerio Mari
, Lorenzo Carriera
, et al.
·
Current Allergy and Asthma Reports
·
8
PDF
Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence
2026
·
Pier-Valerio Mari
, Lorenzo Carriera
, et al.
·
Current Allergy and Asthma Reports
·
8
PDF
How many blood eosinophil measurements are needed to identify COPD patients eligible for biologic therapy? A multi-source decision analysis simulation
2026
·
Pier-Valerio Mari
, Angelo Coppola
, et al.
·
European Journal of Internal Medicine
·
7
Tuberculous pleural effusion: integrating thoracic ultrasound and medical thoracoscopy in the diagnosis and management: a pictorial narrative review and an algorithm proposal
2025
·
Riccardo Inchingolo
, Lorenzo Carriera
, et al.
·
Journal of Ultrasound
·
7
PDF
Ultrasound and Intrapleural Enzymatic Therapy for Complicated Pleural Effusion: A Case Series with a Literature Review
2024
·
Riccardo Inchingolo
, Simone Ielo
, et al.
·
Journal of Clinical Medicine
·
7
Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World Study
2026
·
Lorenzo Carriera
, Angelo Coppola
, et al.
·
Advances in respiratory medicine
·
6
PDF
Combination treatment with monoclonal antibodies for the management of severe asthma and immune-mediated inflammatory diseases: a comprehensive review
2024
·
Lorenzo Carriera
, Sara Caporuscio
, et al.
·
Monaldi Archives for Chest Disease
·
6
PDF
Healthcare worker views on antimicrobial resistance in chronic respiratory disease
2025
·
Sachin Ananth
, Adekunle O. Adeoti
, et al.
·
Antimicrobial Resistance and Infection Control
·
5
PDF
High-flow nasal cannula in severe asthma exacerbations: current evidence and clinical perspectives
2025
·
Lorenzo Carriera
, Simone Ielo
, et al.
·
European Respiratory Review
·
3
COPD Stability and Asthma Remission: Different Words for the Same Therapeutic Ambition?
2026
·
Lorenzo Carriera
, Pier-Valerio Mari
, et al.
·
Biomedicines
·
2
PDF
Upper and lower airway crosstalk in acute exacerbations of COPD: a clinical and biological overview
2026
·
Simone Ielo
, Lorenzo Carriera
, et al.
·
Expert Review of Respiratory Medicine
·
2
PDF
Real-World Dupilumab in Type 2 Chronic Obstructive Pulmonary Disease (COPD): A Single-Centre Compassionate-Use Case Series
2026
·
Pier-Valerio Mari
, Lorenzo Carriera
, et al.
·
Biomedicines
·
2
Switching to dupilumab from other biologic therapies in chronic rhinosinusitis with nasal polyps (CRSWNP): a comparison with biologic-naïve patients
2026
·
Daniela Lucidi
, Veronica Seccia
, et al.
·
European Archives of Oto-Rhino-Laryngology
·
2
An update on the role of ultrasound lung artifacts in the diagnosis of respiratory diseases
2025
·
Gino Soldati
, Andrea Smargiassi
, et al.
·
Expert Review of Respiratory Medicine
·
2
PDF
Simultaneous treatment with benralizumab and ustekinumab in a patient with severe asthma and ulcerative colitis
2024
·
Lorenzo Carriera
, Roberto Barone
, et al.
·
Lung India
·
2
Imatinib-Associated Interstitial Lung Disease with a Fibrotic NSIP Pattern on Transbronchial Lung Cryobiopsy: A Case Report and Review of the Literature
2026
·
Pier-Valerio Mari
, Lorenzo Carriera
, et al.
·
Reports — Medical Cases Images and Videos
·
1
Steroid-sparing biologics in severe asthma and chronic obstructive pulmonary disease: a systematic review, cross-disease meta-analysis, and translational estimate of corticosteroid-related harm prevented
2026
·
Pier-Valerio Mari
, Lorenzo Carriera
, et al.
·
European Journal of Internal Medicine
·
1
PDF
High-Frequency Chest Wall Oscillation in Critical Care: A Systematic Review
2026
·
Simone Ielo
, Lorenzo Carriera
, et al.
·
Respiration
·
1
Red flags for thoracic endometriosis
2025
·
Lorenzo Carriera1,2
, Roberto Lipsi2
, et al.
·
Jornal Brasileiro de Pneumologia
·
1
PDF
An Uncommon Case of Non‐Specific Interstitial Pneumonia ( NSIP ) Associated With Idiopathic Hypereosinophilic Syndrome ( HES ) Reversed by Mepolizumab
2025
·
Roberto Lipsi
, Angelo Coppola
, et al.
·
Respirology Case Reports
·
1
PDF
Show more works
View as search
Works count:
44
Citation count:
166
H-index:
7
I10-index:
2
Year
Topic
Type